Selected Quarterly Financial Data (Unaudited)

12 Months Ended

Jun. 30, 2019

Quarterly Financial Information Disclosure [Abstract]

Selected Quarterly Financial Data (Unaudited)

17. Selected Quarterly Financial Data (Unaudited)

The following is selected quarterly financial data for fiscal 2019 and 2018. The sum of the quarters may not equal year-to-date due to rounding.

(in millions, except per common share amounts)	First Quarter (2)			Second Quarter			Third Quarter		Fourth Quarter
Fiscal 2019
Revenue	$	35,213		$	37,740		$	35,228	$	37,353
Gross margin (1)	1,667			1,730			1,764		1,674
Distribution, selling, general and administrative expenses	1,155			1,064			1,097		1,168
Net earnings	594			281			296		194
Less: Net earnings attributable to noncontrolling interests	(1		)	(1		)	—		—
Net earnings attributable to Cardinal Health, Inc.	593			280			296		194
Net earnings attributable to Cardinal Health, Inc. per common share:
Basic	$	1.95		$	0.94		$	0.99	$	0.65
Diluted	1.94			0.93			0.99		0.65

(1) Gross margin was not impacted by LIFO benefit/(charges) in fiscal 2019.

(2) Includes a $508 million gain ($378 million after-tax) related to the naviHealth divestiture.

(in millions, except per common share amounts)	First Quarter			Second Quarter		Third Quarter		Fourth Quarter
Fiscal 2018
Revenue	$	32,641		$	35,186	$	33,633	$	35,349
Gross margin (1)	1,672			1,861		1,913		1,735
Distribution, selling, general and administrative expenses	1,062			1,131		1,132		1,270
Net earnings/(loss) (2)	117			1,053		255		(1,166		)
Less: Net earnings attributable to noncontrolling interests	(2		)	—		—		—
Net earnings/(loss) attributable to Cardinal Health, Inc.	115			1,053		255		(1,166		)
Net earnings/(loss) attributable to Cardinal Health, Inc. per common share:
Basic	$	0.36		$	3.35	$	0.81	$	(3.76	)
Diluted (3)	0.36			3.33		0.81		(3.76		)

(1) Gross margin was not impacted by LIFO benefit/(charges) in fiscal 2018.

(2) During the fourth quarter of fiscal 2018, we recognized a goodwill impairment charge of $1.4 billion related to our Medical segment. There was no tax benefit related to this goodwill impairment charge.

(3) Due to the net loss during the fourth quarter of fiscal 2018, dilutive potential common shares have not been included in the denominator of the dilutive per share computation due to their antidilutive effect.